120 related articles for article (PubMed ID: 7781800)
1. The prevalence of different human papillomavirus types and p53 mutations in laryngeal carcinomas: is there a reciprocal relationship?
Salam M; Rockett J; Morris A
Eur J Surg Oncol; 1995 Jun; 21(3):290-6. PubMed ID: 7781800
[TBL] [Abstract][Full Text] [Related]
2. Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma.
Soini Y; Nuorva K; Kamel D; Pöllänen R; Vähäkangas K; Lehto VP; Pääkkö P
Thorax; 1996 Sep; 51(9):887-93. PubMed ID: 8984698
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL
J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings.
Gorgoulis V; Rassidakis G; Karameris A; Giatromanolaki A; Barbatis C; Kittas C
Virchows Arch; 1994; 425(5):481-9. PubMed ID: 7850072
[TBL] [Abstract][Full Text] [Related]
5. Lack of synergistic association between human papillomavirus and ras gene point mutation in laryngeal carcinomas.
Shidara K; Suzuki T; Hara F; Nakajima T
Laryngoscope; 1994 Aug; 104(8 Pt 1):1008-12. PubMed ID: 8052064
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus in early laryngeal carcinoma.
Baumann JL; Cohen S; Evjen AN; Law JH; Vadivelu S; Attia A; Schindler JS; Chung CH; Wirth PS; Meijer CJ; Snijders PJ; Yarbrough WG; Slebos RJ
Laryngoscope; 2009 Aug; 119(8):1531-7. PubMed ID: 19489068
[TBL] [Abstract][Full Text] [Related]
7. Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma.
Khurshid A; Kazuya N; Hanae I; Manabu I
J Pak Med Assoc; 1998 May; 48(5):138-42. PubMed ID: 9813975
[TBL] [Abstract][Full Text] [Related]
8. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone.
Ishikawa H; Mitsuhashi N; Sakurai H; Maebayashi K; Niibe H
Cancer; 2001 Jan; 91(1):80-9. PubMed ID: 11148563
[TBL] [Abstract][Full Text] [Related]
9. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
10. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer.
Moonen PM; Bakkers JM; Kiemeney LA; Schalken JA; Melchers WJ; Witjes JA
Eur Urol; 2007 Aug; 52(2):464-8. PubMed ID: 17116360
[TBL] [Abstract][Full Text] [Related]
11. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours.
Crook T; Wrede D; Tidy JA; Mason WP; Evans DJ; Vousden KH
Lancet; 1992 May; 339(8801):1070-3. PubMed ID: 1349102
[TBL] [Abstract][Full Text] [Related]
12. p53 Codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumours.
Sourvinos G; Rizos E; Spandidos DA
Oral Oncol; 2001 Oct; 37(7):572-8. PubMed ID: 11564578
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
14. Cellular manifestations of human papillomavirus infection in laryngeal tissues.
Jacob SE; Sreevidya S; Chacko E; Pillai MR
J Surg Oncol; 2002 Mar; 79(3):142-50. PubMed ID: 11870663
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of tumour suppressor gene p53 in laryngeal squamous cell carcinomas and its prognostic significance.
Salam MA; Crocker J; Morris A
Clin Otolaryngol Allied Sci; 1995 Feb; 20(1):49-52. PubMed ID: 7788934
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma.
Almadori G; Cadoni G; Cattani P; Galli J; Bussu F; Ferrandina G; Scambia G; Fadda G; Maurizi M
Clin Cancer Res; 2001 Dec; 7(12):3988-93. PubMed ID: 11751491
[TBL] [Abstract][Full Text] [Related]
17. Telomerase, p53 and human papillomavirus infection in the uterine cervix.
Nair P; Jayaprakash PG; Nair MK; Pillai MR
Acta Oncol; 2000; 39(1):65-70. PubMed ID: 10752656
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression and mutation of p53 in cervical cancer--a study at protein, RNA and DNA levels.
Ngan HY; Tsao SW; Liu SS; Stanley M
Genitourin Med; 1997 Feb; 73(1):54-8. PubMed ID: 9155557
[TBL] [Abstract][Full Text] [Related]
19. The role of p53 inactivation in human cervical cell carcinoma development.
Miwa K; Miyamoto S; Kato H; Imamura T; Nishida M; Yoshikawa Y; Nagata Y; Wake N
Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
[TBL] [Abstract][Full Text] [Related]
20. High frequency of p53 abnormality in laryngeal cancers of heavy smokers and its relation to human papillomavirus infection.
Suzuki T; Shidara K; Hara F; Nakajima T
Jpn J Cancer Res; 1994 Nov; 85(11):1087-93. PubMed ID: 7829392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
